Global Devices for Inhaled Medications Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Devices for Inhaled Medications Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Devices for Inhaled Medications by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Devices for Inhaled Medications by Country/Region, 2017, 2022 & 2028

2.2 Devices for Inhaled Medications Segment by Type

2.2.1 Dry Powder Inhalers

2.2.2 Metered-Dose Inhalers

2.2.3 Nebulizers

2.2.4 Soft Mist Inhaler

2.3 Devices for Inhaled Medications Sales by Type

2.3.1 Global Devices for Inhaled Medications Sales Market Share by Type (2017-2022)

2.3.2 Global Devices for Inhaled Medications Revenue and Market Share by Type (2017-2022)

2.3.3 Global Devices for Inhaled Medications Sale Price by Type (2017-2022)

2.4 Devices for Inhaled Medications Segment by Application

2.4.1 Clinic

2.4.2 Hospital

2.4.3 Household

2.5 Devices for Inhaled Medications Sales by Application

2.5.1 Global Devices for Inhaled Medications Sale Market Share by Application (2017-2022)

2.5.2 Global Devices for Inhaled Medications Revenue and Market Share by Application (2017-2022)

2.5.3 Global Devices for Inhaled Medications Sale Price by Application (2017-2022)

3 Global Devices for Inhaled Medications by Company

3.1 Global Devices for Inhaled Medications Breakdown Data by Company

3.1.1 Global Devices for Inhaled Medications Annual Sales by Company (2020-2022)

3.1.2 Global Devices for Inhaled Medications Sales Market Share by Company (2020-2022)

3.2 Global Devices for Inhaled Medications Annual Revenue by Company (2020-2022)

3.2.1 Global Devices for Inhaled Medications Revenue by Company (2020-2022)

3.2.2 Global Devices for Inhaled Medications Revenue Market Share by Company (2020-2022)

3.3 Global Devices for Inhaled Medications Sale Price by Company

3.4 Key Manufacturers Devices for Inhaled Medications Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Devices for Inhaled Medications Product Location Distribution

3.4.2 Players Devices for Inhaled Medications Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Devices for Inhaled Medications by Geographic Region

4.1 World Historic Devices for Inhaled Medications Market Size by Geographic Region (2017-2022)

4.1.1 Global Devices for Inhaled Medications Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Devices for Inhaled Medications Annual Revenue by Geographic Region

4.2 World Historic Devices for Inhaled Medications Market Size by Country/Region (2017-2022)

4.2.1 Global Devices for Inhaled Medications Annual Sales by Country/Region (2017-2022)

4.2.2 Global Devices for Inhaled Medications Annual Revenue by Country/Region

4.3 Americas Devices for Inhaled Medications Sales Growth

4.4 APAC Devices for Inhaled Medications Sales Growth

4.5 Europe Devices for Inhaled Medications Sales Growth

4.6 Middle East & Africa Devices for Inhaled Medications Sales Growth

5 Americas

5.1 Americas Devices for Inhaled Medications Sales by Country

5.1.1 Americas Devices for Inhaled Medications Sales by Country (2017-2022)

5.1.2 Americas Devices for Inhaled Medications Revenue by Country (2017-2022)

5.2 Americas Devices for Inhaled Medications Sales by Type

5.3 Americas Devices for Inhaled Medications Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Devices for Inhaled Medications Sales by Region

6.1.1 APAC Devices for Inhaled Medications Sales by Region (2017-2022)

6.1.2 APAC Devices for Inhaled Medications Revenue by Region (2017-2022)

6.2 APAC Devices for Inhaled Medications Sales by Type

6.3 APAC Devices for Inhaled Medications Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Devices for Inhaled Medications by Country

7.1.1 Europe Devices for Inhaled Medications Sales by Country (2017-2022)

7.1.2 Europe Devices for Inhaled Medications Revenue by Country (2017-2022)

7.2 Europe Devices for Inhaled Medications Sales by Type

7.3 Europe Devices for Inhaled Medications Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Devices for Inhaled Medications by Country

8.1.1 Middle East & Africa Devices for Inhaled Medications Sales by Country (2017-2022)

8.1.2 Middle East & Africa Devices for Inhaled Medications Revenue by Country (2017-2022)

8.2 Middle East & Africa Devices for Inhaled Medications Sales by Type

8.3 Middle East & Africa Devices for Inhaled Medications Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Devices for Inhaled Medications

10.3 Manufacturing Process Analysis of Devices for Inhaled Medications

10.4 Industry Chain Structure of Devices for Inhaled Medications

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Devices for Inhaled Medications Distributors

11.3 Devices for Inhaled Medications Customer

12 World Forecast Review for Devices for Inhaled Medications by Geographic Region

12.1 Global Devices for Inhaled Medications Market Size Forecast by Region

12.1.1 Global Devices for Inhaled Medications Forecast by Region (2023-2028)

12.1.2 Global Devices for Inhaled Medications Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Devices for Inhaled Medications Forecast by Type

12.7 Global Devices for Inhaled Medications Forecast by Application

13 Key Players Analysis

13.1 Consort Medical

13.1.1 Consort Medical Company Information

13.1.2 Consort Medical Devices for Inhaled Medications Product Offered

13.1.3 Consort Medical Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Consort Medical Main Business Overview

13.1.5 Consort Medical Latest Developments

13.2 Inhalexper

13.2.1 Inhalexper Company Information

13.2.2 Inhalexper Devices for Inhaled Medications Product Offered

13.2.3 Inhalexper Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Inhalexper Main Business Overview

13.2.5 Inhalexper Latest Developments

13.3 Cambridge Consultants

13.3.1 Cambridge Consultants Company Information

13.3.2 Cambridge Consultants Devices for Inhaled Medications Product Offered

13.3.3 Cambridge Consultants Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Cambridge Consultants Main Business Overview

13.3.5 Cambridge Consultants Latest Developments

13.4 Hovione

13.4.1 Hovione Company Information

13.4.2 Hovione Devices for Inhaled Medications Product Offered

13.4.3 Hovione Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Hovione Main Business Overview

13.4.5 Hovione Latest Developments

13.5 Catalent, Inc

13.5.1 Catalent, Inc Company Information

13.5.2 Catalent, Inc Devices for Inhaled Medications Product Offered

13.5.3 Catalent, Inc Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Catalent, Inc Main Business Overview

13.5.5 Catalent, Inc Latest Developments

13.6 VertMarkets, Inc

13.6.1 VertMarkets, Inc Company Information

13.6.2 VertMarkets, Inc Devices for Inhaled Medications Product Offered

13.6.3 VertMarkets, Inc Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 VertMarkets, Inc Main Business Overview

13.6.5 VertMarkets, Inc Latest Developments

13.7 Qualicaps

13.7.1 Qualicaps Company Information

13.7.2 Qualicaps Devices for Inhaled Medications Product Offered

13.7.3 Qualicaps Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Qualicaps Main Business Overview

13.7.5 Qualicaps Latest Developments

13.8 3M

13.8.1 3M Company Information

13.8.2 3M Devices for Inhaled Medications Product Offered

13.8.3 3M Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 3M Main Business Overview

13.8.5 3M Latest Developments

13.9 Aerovance

13.9.1 Aerovance Company Information

13.9.2 Aerovance Devices for Inhaled Medications Product Offered

13.9.3 Aerovance Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Aerovance Main Business Overview

13.9.5 Aerovance Latest Developments

13.10 AstraZeneca

13.10.1 AstraZeneca Company Information

13.10.2 AstraZeneca Devices for Inhaled Medications Product Offered

13.10.3 AstraZeneca Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 AstraZeneca Main Business Overview

13.10.5 AstraZeneca Latest Developments

13.11 Boehringer Ingelheim

13.11.1 Boehringer Ingelheim Company Information

13.11.2 Boehringer Ingelheim Devices for Inhaled Medications Product Offered

13.11.3 Boehringer Ingelheim Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Boehringer Ingelheim Main Business Overview

13.11.5 Boehringer Ingelheim Latest Developments

13.12 Chiesi

13.12.1 Chiesi Company Information

13.12.2 Chiesi Devices for Inhaled Medications Product Offered

13.12.3 Chiesi Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Chiesi Main Business Overview

13.12.5 Chiesi Latest Developments

13.13 Cipla

13.13.1 Cipla Company Information

13.13.2 Cipla Devices for Inhaled Medications Product Offered

13.13.3 Cipla Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Cipla Main Business Overview

13.13.5 Cipla Latest Developments

13.14 Civitas/Alkermes

13.14.1 Civitas/Alkermes Company Information

13.14.2 Civitas/Alkermes Devices for Inhaled Medications Product Offered

13.14.3 Civitas/Alkermes Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Civitas/Alkermes Main Business Overview

13.14.5 Civitas/Alkermes Latest Developments

13.15 GlaxoSmithKline

13.15.1 GlaxoSmithKline Company Information

13.15.2 GlaxoSmithKline Devices for Inhaled Medications Product Offered

13.15.3 GlaxoSmithKline Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 GlaxoSmithKline Main Business Overview

13.15.5 GlaxoSmithKline Latest Developments

13.16 Hovione

13.16.1 Hovione Company Information

13.16.2 Hovione Devices for Inhaled Medications Product Offered

13.16.3 Hovione Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Hovione Main Business Overview

13.16.5 Hovione Latest Developments

13.17 Mannkind

13.17.1 Mannkind Company Information

13.17.2 Mannkind Devices for Inhaled Medications Product Offered

13.17.3 Mannkind Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Mannkind Main Business Overview

13.17.5 Mannkind Latest Developments

13.18 Mantecorp

13.18.1 Mantecorp Company Information

13.18.2 Mantecorp Devices for Inhaled Medications Product Offered

13.18.3 Mantecorp Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Mantecorp Main Business Overview

13.18.5 Mantecorp Latest Developments

13.19 Meda

13.19.1 Meda Company Information

13.19.2 Meda Devices for Inhaled Medications Product Offered

13.19.3 Meda Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Meda Main Business Overview

13.19.5 Meda Latest Developments

13.20 MicroDose Therapeutx

13.20.1 MicroDose Therapeutx Company Information

13.20.2 MicroDose Therapeutx Devices for Inhaled Medications Product Offered

13.20.3 MicroDose Therapeutx Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 MicroDose Therapeutx Main Business Overview

13.20.5 MicroDose Therapeutx Latest Developments

13.21 Novartis

13.21.1 Novartis Company Information

13.21.2 Novartis Devices for Inhaled Medications Product Offered

13.21.3 Novartis Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Novartis Main Business Overview

13.21.5 Novartis Latest Developments

14 Research Findings and Conclusion

Table 1. Devices for Inhaled Medications Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Devices for Inhaled Medications Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Dry Powder Inhalers

Table 4. Major Players of Metered-Dose Inhalers

Table 5. Major Players of Nebulizers

Table 6. Major Players of Soft Mist Inhaler

Table 7. Global Devices for Inhaled Medications Sales by Type (2017-2022) & (K Units)

Table 8. Global Devices for Inhaled Medications Sales Market Share by Type (2017-2022)

Table 9. Global Devices for Inhaled Medications Revenue by Type (2017-2022) & ($ million)

Table 10. Global Devices for Inhaled Medications Revenue Market Share by Type (2017-2022)

Table 11. Global Devices for Inhaled Medications Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Devices for Inhaled Medications Sales by Application (2017-2022) & (K Units)

Table 13. Global Devices for Inhaled Medications Sales Market Share by Application (2017-2022)

Table 14. Global Devices for Inhaled Medications Revenue by Application (2017-2022)

Table 15. Global Devices for Inhaled Medications Revenue Market Share by Application (2017-2022)

Table 16. Global Devices for Inhaled Medications Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Devices for Inhaled Medications Sales by Company (2020-2022) & (K Units)

Table 18. Global Devices for Inhaled Medications Sales Market Share by Company (2020-2022)

Table 19. Global Devices for Inhaled Medications Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Devices for Inhaled Medications Revenue Market Share by Company (2020-2022)

Table 21. Global Devices for Inhaled Medications Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Devices for Inhaled Medications Producing Area Distribution and Sales Area

Table 23. Players Devices for Inhaled Medications Products Offered

Table 24. Devices for Inhaled Medications Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Devices for Inhaled Medications Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Devices for Inhaled Medications Sales Market Share Geographic Region (2017-2022)

Table 29. Global Devices for Inhaled Medications Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Devices for Inhaled Medications Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Devices for Inhaled Medications Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Devices for Inhaled Medications Sales Market Share by Country/Region (2017-2022)

Table 33. Global Devices for Inhaled Medications Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Devices for Inhaled Medications Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Devices for Inhaled Medications Sales by Country (2017-2022) & (K Units)

Table 36. Americas Devices for Inhaled Medications Sales Market Share by Country (2017-2022)

Table 37. Americas Devices for Inhaled Medications Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Devices for Inhaled Medications Revenue Market Share by Country (2017-2022)

Table 39. Americas Devices for Inhaled Medications Sales by Type (2017-2022) & (K Units)

Table 40. Americas Devices for Inhaled Medications Sales Market Share by Type (2017-2022)

Table 41. Americas Devices for Inhaled Medications Sales by Application (2017-2022) & (K Units)

Table 42. Americas Devices for Inhaled Medications Sales Market Share by Application (2017-2022)

Table 43. APAC Devices for Inhaled Medications Sales by Region (2017-2022) & (K Units)

Table 44. APAC Devices for Inhaled Medications Sales Market Share by Region (2017-2022)

Table 45. APAC Devices for Inhaled Medications Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Devices for Inhaled Medications Revenue Market Share by Region (2017-2022)

Table 47. APAC Devices for Inhaled Medications Sales by Type (2017-2022) & (K Units)

Table 48. APAC Devices for Inhaled Medications Sales Market Share by Type (2017-2022)

Table 49. APAC Devices for Inhaled Medications Sales by Application (2017-2022) & (K Units)

Table 50. APAC Devices for Inhaled Medications Sales Market Share by Application (2017-2022)

Table 51. Europe Devices for Inhaled Medications Sales by Country (2017-2022) & (K Units)

Table 52. Europe Devices for Inhaled Medications Sales Market Share by Country (2017-2022)

Table 53. Europe Devices for Inhaled Medications Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Devices for Inhaled Medications Revenue Market Share by Country (2017-2022)

Table 55. Europe Devices for Inhaled Medications Sales by Type (2017-2022) & (K Units)

Table 56. Europe Devices for Inhaled Medications Sales Market Share by Type (2017-2022)

Table 57. Europe Devices for Inhaled Medications Sales by Application (2017-2022) & (K Units)

Table 58. Europe Devices for Inhaled Medications Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Devices for Inhaled Medications Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Devices for Inhaled Medications Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Devices for Inhaled Medications Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Devices for Inhaled Medications Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Devices for Inhaled Medications Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Devices for Inhaled Medications Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Devices for Inhaled Medications Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Devices for Inhaled Medications Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Devices for Inhaled Medications

Table 68. Key Market Challenges & Risks of Devices for Inhaled Medications

Table 69. Key Industry Trends of Devices for Inhaled Medications

Table 70. Devices for Inhaled Medications Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Devices for Inhaled Medications Distributors List

Table 73. Devices for Inhaled Medications Customer List

Table 74. Global Devices for Inhaled Medications Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Devices for Inhaled Medications Sales Market Forecast by Region

Table 76. Global Devices for Inhaled Medications Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Devices for Inhaled Medications Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Devices for Inhaled Medications Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Devices for Inhaled Medications Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Devices for Inhaled Medications Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Devices for Inhaled Medications Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Devices for Inhaled Medications Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Devices for Inhaled Medications Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Devices for Inhaled Medications Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Devices for Inhaled Medications Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Devices for Inhaled Medications Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Devices for Inhaled Medications Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Devices for Inhaled Medications Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Devices for Inhaled Medications Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Devices for Inhaled Medications Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Devices for Inhaled Medications Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Devices for Inhaled Medications Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Devices for Inhaled Medications Revenue Market Share Forecast by Application (2023-2028)

Table 94. Consort Medical Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 95. Consort Medical Devices for Inhaled Medications Product Offered

Table 96. Consort Medical Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. Consort Medical Main Business

Table 98. Consort Medical Latest Developments

Table 99. Inhalexper Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 100. Inhalexper Devices for Inhaled Medications Product Offered

Table 101. Inhalexper Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Inhalexper Main Business

Table 103. Inhalexper Latest Developments

Table 104. Cambridge Consultants Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 105. Cambridge Consultants Devices for Inhaled Medications Product Offered

Table 106. Cambridge Consultants Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Cambridge Consultants Main Business

Table 108. Cambridge Consultants Latest Developments

Table 109. Hovione Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 110. Hovione Devices for Inhaled Medications Product Offered

Table 111. Hovione Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Hovione Main Business

Table 113. Hovione Latest Developments

Table 114. Catalent, Inc Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 115. Catalent, Inc Devices for Inhaled Medications Product Offered

Table 116. Catalent, Inc Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. Catalent, Inc Main Business

Table 118. Catalent, Inc Latest Developments

Table 119. VertMarkets, Inc Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 120. VertMarkets, Inc Devices for Inhaled Medications Product Offered

Table 121. VertMarkets, Inc Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. VertMarkets, Inc Main Business

Table 123. VertMarkets, Inc Latest Developments

Table 124. Qualicaps Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 125. Qualicaps Devices for Inhaled Medications Product Offered

Table 126. Qualicaps Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Qualicaps Main Business

Table 128. Qualicaps Latest Developments

Table 129. 3M Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 130. 3M Devices for Inhaled Medications Product Offered

Table 131. 3M Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. 3M Main Business

Table 133. 3M Latest Developments

Table 134. Aerovance Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 135. Aerovance Devices for Inhaled Medications Product Offered

Table 136. Aerovance Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. Aerovance Main Business

Table 138. Aerovance Latest Developments

Table 139. AstraZeneca Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 140. AstraZeneca Devices for Inhaled Medications Product Offered

Table 141. AstraZeneca Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. AstraZeneca Main Business

Table 143. AstraZeneca Latest Developments

Table 144. Boehringer Ingelheim Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 145. Boehringer Ingelheim Devices for Inhaled Medications Product Offered

Table 146. Boehringer Ingelheim Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 147. Boehringer Ingelheim Main Business

Table 148. Boehringer Ingelheim Latest Developments

Table 149. Chiesi Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 150. Chiesi Devices for Inhaled Medications Product Offered

Table 151. Chiesi Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 152. Chiesi Main Business

Table 153. Chiesi Latest Developments

Table 154. Cipla Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 155. Cipla Devices for Inhaled Medications Product Offered

Table 156. Cipla Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 157. Cipla Main Business

Table 158. Cipla Latest Developments

Table 159. Civitas/Alkermes Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 160. Civitas/Alkermes Devices for Inhaled Medications Product Offered

Table 161. Civitas/Alkermes Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 162. Civitas/Alkermes Main Business

Table 163. Civitas/Alkermes Latest Developments

Table 164. GlaxoSmithKline Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 165. GlaxoSmithKline Devices for Inhaled Medications Product Offered

Table 166. GlaxoSmithKline Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 167. GlaxoSmithKline Main Business

Table 168. GlaxoSmithKline Latest Developments

Table 169. Hovione Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 170. Hovione Devices for Inhaled Medications Product Offered

Table 171. Hovione Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 172. Hovione Main Business

Table 173. Hovione Latest Developments

Table 174. Mannkind Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 175. Mannkind Devices for Inhaled Medications Product Offered

Table 176. Mannkind Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 177. Mannkind Main Business

Table 178. Mannkind Latest Developments

Table 179. Mantecorp Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 180. Mantecorp Devices for Inhaled Medications Product Offered

Table 181. Mantecorp Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 182. Mantecorp Main Business

Table 183. Mantecorp Latest Developments

Table 184. Meda Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 185. Meda Devices for Inhaled Medications Product Offered

Table 186. Meda Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 187. Meda Main Business

Table 188. Meda Latest Developments

Table 189. MicroDose Therapeutx Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 190. MicroDose Therapeutx Devices for Inhaled Medications Product Offered

Table 191. MicroDose Therapeutx Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 192. MicroDose Therapeutx Main Business

Table 193. MicroDose Therapeutx Latest Developments

Table 194. Novartis Basic Information, Devices for Inhaled Medications Manufacturing Base, Sales Area and Its Competitors

Table 195. Novartis Devices for Inhaled Medications Product Offered

Table 196. Novartis Devices for Inhaled Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 197. Novartis Main Business

Table 198. Novartis Latest Developments

List of Figures

Figure 1. Picture of Devices for Inhaled Medications

Figure 2. Devices for Inhaled Medications Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Devices for Inhaled Medications Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Devices for Inhaled Medications Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Devices for Inhaled Medications Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Dry Powder Inhalers

Figure 10. Product Picture of Metered-Dose Inhalers

Figure 11. Product Picture of Nebulizers

Figure 12. Product Picture of Soft Mist Inhaler

Figure 13. Global Devices for Inhaled Medications Sales Market Share by Type in 2021

Figure 14. Global Devices for Inhaled Medications Revenue Market Share by Type (2017-2022)

Figure 15. Devices for Inhaled Medications Consumed in Clinic

Figure 16. Global Devices for Inhaled Medications Market: Clinic (2017-2022) & (K Units)

Figure 17. Devices for Inhaled Medications Consumed in Hospital

Figure 18. Global Devices for Inhaled Medications Market: Hospital (2017-2022) & (K Units)

Figure 19. Devices for Inhaled Medications Consumed in Household

Figure 20. Global Devices for Inhaled Medications Market: Household (2017-2022) & (K Units)

Figure 21. Global Devices for Inhaled Medications Sales Market Share by Application (2017-2022)

Figure 22. Global Devices for Inhaled Medications Revenue Market Share by Application in 2021

Figure 23. Devices for Inhaled Medications Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Devices for Inhaled Medications Revenue Market Share by Company in 2021

Figure 25. Global Devices for Inhaled Medications Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Devices for Inhaled Medications Revenue Market Share by Geographic Region in 2021

Figure 27. Global Devices for Inhaled Medications Sales Market Share by Region (2017-2022)

Figure 28. Global Devices for Inhaled Medications Revenue Market Share by Country/Region in 2021

Figure 29. Americas Devices for Inhaled Medications Sales 2017-2022 (K Units)

Figure 30. Americas Devices for Inhaled Medications Revenue 2017-2022 ($ Millions)

Figure 31. APAC Devices for Inhaled Medications Sales 2017-2022 (K Units)

Figure 32. APAC Devices for Inhaled Medications Revenue 2017-2022 ($ Millions)

Figure 33. Europe Devices for Inhaled Medications Sales 2017-2022 (K Units)

Figure 34. Europe Devices for Inhaled Medications Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Devices for Inhaled Medications Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Devices for Inhaled Medications Revenue 2017-2022 ($ Millions)

Figure 37. Americas Devices for Inhaled Medications Sales Market Share by Country in 2021

Figure 38. Americas Devices for Inhaled Medications Revenue Market Share by Country in 2021

Figure 39. United States Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Devices for Inhaled Medications Sales Market Share by Region in 2021

Figure 44. APAC Devices for Inhaled Medications Revenue Market Share by Regions in 2021

Figure 45. China Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Devices for Inhaled Medications Sales Market Share by Country in 2021

Figure 52. Europe Devices for Inhaled Medications Revenue Market Share by Country in 2021

Figure 53. Germany Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Devices for Inhaled Medications Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Devices for Inhaled Medications Revenue Market Share by Country in 2021

Figure 60. Egypt Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Devices for Inhaled Medications Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Devices for Inhaled Medications in 2021

Figure 66. Manufacturing Process Analysis of Devices for Inhaled Medications

Figure 67. Industry Chain Structure of Devices for Inhaled Medications

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles